Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes

por Suzuki, Katsunori, Mitsuma, Yurie, Sato, Takaaki, Anraku, Takumi, Hatta, Mariko
Publicado 2016

Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex

por Matsubayashi, Yasuhiro, Fujihara, Kazuya, Yamada-Harada, Mayuko, Mitsuma, Yurie, Sato, Takaaki, Yaguchi, Yuta, Osawa, Taeko, Yamamoto, Masahiko, Kitazawa, Masaru, Yamada, Takaho, Kodama, Satoru, Sone, Hirohito
Publicado 2022